Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
L. Gonzalez Castro MD, PhD

L. Nicolas Gonzalez Castro MD, PhD

Associate Neurologist, Department of Neurology, Brigham and Women's Hospital; Neuro-Oncologist, Center for Neuro-Oncology, Dana-Farber Cancer Institute; Assistant Professor of Neurology, Harvard Medical School, Boston, MA

Nicolas Gonzalez Castro, MD, PhD is a neurologist and neuro-oncologist at the Department of Neurology, Brigham and Women's Hospital, and Center for Neuro-Oncology, Dana-Farber Cancer Institute. He trained in systems neuroscience and computational biology as an MD-PhD student at the Harvard-MIT Division of Health Sciences and Technology, and completed his neurology residency at the Harvard Neurology Residency Program (Massachusetts General Hospital / Brigham and Women's Hospital). He did his neuro-oncology training at the Massachusetts General Hospital Cancer Center / Brigham and Women's Hospital - Dana Farber Cancer Center Fellowship Program. His current research focus is in understanding the cellular programs that underlie differentiation, survival and resistance to treatment in primary brain tumors.


Dr. Gonzalez Castro reports the following disclosures:

Elsevier, Oakstone Publishing, BMJ Best Practice, Teladoc. Research funding from Merck & Co (to the Dana-Farber Cancer Institute).

His spouse receives salary and stock from Takeda Pharmaceuticals.